- -- Quick Links --
-
- Home
- The focus
- Organizers
- FABA
- Pharmexcil
- Industry Speak
- BioAsia 2012
- BioAsia 2011
- BioAsia 2010
- BioAsia 2009
- Proceedings 2012
- Proceedings 2011
- Proceedings 2010
- Proceedings 2009
- Awards-2012
- Awards-2011
- Awards-2010
- Awards-2009
- Photo Gallery 2012
- Photo Gallery 2011
- Photo Gallery 2010
- Photo Gallery 2009
- Video Gallery 2012
- Video Gallery 2011
- Presentation
- Publications
- Contact Us
Archives
Archives
Speakers Profile
Dr. Martin Mackay
Martin Mackay is the President of Pfizer Global Research and Development (PGRD). Martin oversees more than 9,000 employees spanning across the globe, 9 therapeutic areas and several functional lines (Research, Development Operations, Regulatory Affairs and Quality Assurance, Pharmaceutical Sciences, Drug Safety, etc). Martin began his career at Pfizer in 1995 as the Director of Discovery Biology in the UK.
Mr. Stefan Borgas
Undergraduate in business administration from the University of Saarbrücken, Graduate from University of St.Gallen, Switzerland, specializing in marketing and management.
Dr. Swaminathan Subramaniam
Undergraduate in business administration from the University of Saarbrücken, Graduate from University of St.Gallen, Switzerland, specializing in marketing and management.
Dr. Reid Leonard
Dr. Reid Leonard is the Executive Director, External Research and Licensing for the Merck Research Laboratories, Merck & Co., Inc. Reid's role is to identify partnering opportunities that fit with Merck's strategic research and development objectives in key franchise areas.
Prof. Abbas S. Lotfi
As part of NIGEB decisions, expansion of the international collaboration is a principal policy, focuses on cooperation between developing countries.
Prof. Brian F Clark
Dr. Reid Leonard is the Executive Director, External Research and Licensing for the Merck Research Laboratories, Merck & Co., Inc. Reid's role is to identify partnering opportunities that fit with Merck's strategic research and development objectives in key franchise areas.
Dr. Ravi Sodha
Dr. Sodha studied in the UK obtaining B.Sc. in Pharmacology, Ph.D. and MBA. He started his career in basic research almost 25 years ago, first at London University, then at Zurich University Hospitals and later Ciba Geigy Basel.
Mr. Sarath Naru
Sarath has been focused on venture capital/private equity in India for more than ten years, investing in rapidly growing businesses across tech, biotech, and manufacturing sectors. He is the Managing Partner of VenturEast Funds which has over $300 million under management. VenturEast has consistently raised funds with a pioneering investment focus.
Dr. Aditya Kapil
Dr. Aditya Kapil has significant life sciences exposure both in India and overseas (UK & US). He leads the early-stage drug discovery deals in Ventureast's life sciences portfolio. Dr. Kapil has deep experience in setting up Indian operations for overseas companies that benefit from Indian scientific and operational advantages.
Dr. Jasmine Patel
Dr. Jasmin Patel is Managing Director at FIL Capital Advisors (India), Fidelity's Private Equity and Growth Capital Fund focused on India. In this role, he drives investments into the lifesciences sectors including pharma, biotech, services and devices by the Fidelity team of 7 experienced professionals based in Mumbai and together with another 20 lifescience focused investor colleagues in other parts of the world.
Dr. Prasad Sunkara
Dr. Prasad Sunkara, a serial entrepreneur, combines over 30 years of corporate, financing, business development, research, development and management experience in cancer, cardiovascular and CNS disease indications at Marion Merrell Dow pharmaceuticals (now Sanofi Aventis) and eight other successful start up biotech companies in California and Michigan.
Dr. Chris Lowe
He has been involved in creating a seamless interface between academia and industry and developing new mechanisms designed to transfer quality science from the academic to the private sector; the Institute of Biotechnology is a working example of this.
Dr. Krishna M. Ella
Dr. Krishna M. Ella, moved back to India in 1996 after completing higher studies at the University of Hawaii, The University of Wisconsin-Madison and serving as Asst. Professor at the Medical University of South Carolina in USA. His quest for uniqueness has transformed him into a Bio-entrepreneur, which leads to the birth of Bharat Biotech International Ltd at Hyderabad.
Mr. Swapan Bhattacharya
Dr. Krishna M. Ella, moved back to India in 1996 after completing higher studies at the University of Hawaii, The University of Wisconsin-Madison and serving as Asst. Professor at the Medical University of South Carolina in USA. His quest for uniqueness has transformed him into a Bio-entrepreneur, which leads to the birth of Bharat Biotech International Ltd at Hyderabad.
Dr. Rashmi.H. Barbhaiya
Rashmi H. Barbhaiya, Ph.D. is a Pharmaceutical Executive with 27 years of experience in Pharmaceutical R&D. He is one of the founders, CEO and Managing Director of Advinus Therapeutics, a research-based pharma company located in Bangalore and Poona, India.
Dr. Hartmut Kühn
With a teaching and research experience of nearly 30 years, he is currently research group leader at the Institute of Biochemistry, University Medicine Berlin – Charité.
Dr. Manni Kantipudi
Manni Kantipudi joined GVK BIO as the President in 2007. He brings a unique blend of services, international management and product development experience. He has done his Bachelors in Computer Engineering and Masters in Computer Science.
Dr J Gowrishankar
He was a Scientist (Group Leader), Centre for Cellular and Molecular Biology, Hyderabad; has been associated with Centre for DNA Fingerprinting and Diagnostics since 2000.
Dr. Robert W. Naismith
Dr. Naismith serves as Chairman and CEO of Roosevelt Capital Partners, LLC. Formerly he served as Chairman and CEO of Life Science Analytics and Managing Director of London-based Datamonitor, Inc. Dr. Naismith co-founded Pharmakon Research International, Inc., a major international preclinical contract research organization.
Dr. Vijay Ramakrishnan
Dr. Ramakrishnan has twenty one years of combined experience in protein biotechnology research; equity research and investment banking in biotechnology industry; and in building biotechnology companies with a particular emphasis on the discovery and development of therapeutic antibodies, antibody engineering, and stratified medicine.
Dr. Amitabha Chaudhuri
Generation and maintenance of cell polarity in yeast. Protein-protein interaction map of Drosophila. Developed a new method of analyzing microarray data (PADGE) to discover novel cancer targets. Mechanism of receptor tyrosine kinase signaling.
Dr. Shireen Vali
Shireen, a Cellworks co-founder is a member of the senior executive team. She manages Cellworks Research and Development groups.
Dr. Barry Furr
He is a reproductive biologist and endocrinologist by training who worked for over 33 years at AstraZeneca and its associate companies.
Dr. K. I. Varaprasad Reddy
He is a reproductive biologist and endocrinologist by training who worked for over 33 years at AstraZeneca and its associate companies.
Dr. Albrecht Läufer
Corvay provides expert consultancy in Life Sciences to customers in Germany and internationally, with a special focus on Asia.
Mr. Martin Gotting
Martin Götting is Vice President Marketing, Sales and Supply for Europe, Asia, Australia and ROW at Intercell AG, a fast growing biotech company that develops novel vaccines. He has a broad experience in the biotechnology and healthcare field.
Dr. Raman Rao
As head of clinical research and Medico-marketing, he is responsible for conducting pre-registration clinical trials for recombinant products, vaccines and diagnostic kits. Designing protocols and other clinical research material.
Dr. S. Chandrasegaran
The major goal of this project is to design a synthetic life form based on Saccharomyces cerevisiae that will be used to answer a wide variety of profound biological questions, including the minimum gene set compatible with free-living eukaryotic life and the fundamental requirements for genome and chomosome stability.
Prof. C. Channa Reddy
Gained international prominence as an expert in the molecular enzymology of glutathione requiring enzymes, increase knowledge of the molecular mechanisms involved in or responsible for regulating the biosynthesis of prostaglandins (PGs) and leukotrienes (LTs) by vitamin E and selenium.
Mrs. Jumana Barnagarwala
Jumana is a seasoned pharmaceutical sales and marketing professional with a 10 years of experience spanning various sales and marketing roles in two of the leading pharmaceutical companies in India –SmithKline Beecham (GSK) and AstraZeneca.
Dr. John M Hyde
John Hyde is Chairman and Founder of Hyde Engineering & Consulting, Inc., founded in 1993 and specializing in process systems engineering, compliance consulting and process, cleaning, sterilization and equipment validation for biopharmaceutical and pharmaceutical process systems.
Dr. P. B. A. Nanda Kumar
Focuses on intellectual property and life sciences transactions. His patent prosecution concentrates primarily on biotechnology, medical diagnostics and pharmaceutical areas, and he also counsels clients regarding intellectual property licensing, due diligence and infringement matters.
Prof. P. Reddanna
Prof. Reddanna has been working in the area inflammation and cancer, specifically on the role of polyunsaturated fatty acids (PUFAs) and eicosanoids for the past 30 years.
Dr. Sundara Ramaprabhu
Alaxander von Humboldt-Stiftung (AvH) Fellow, Germany; DAAD Fellow, Germany; Visiting Fellow to Germany by BMBF & DFG German Science Foundations & Visiting Fellow to South Korea.
Prof. Devraj Rambhau
Novel drug delivery systems including liposomes, niosomes, micellar systems, lipid microspheres and lipid nanoparticles.
Dr. M. Rami Reddy
Dr. Rami Reddy Mutyala (Dr. Reddy) is a co-founder and chairman of RR Labs Inc., based in San Diego, California, USA, and Rational Labs Pvt. Limited, based in Hyderabad.
Dr. Chandra U. Singh
Prior to founding Trinity Laboratories Inc. in 2006, Dr. Chandra Singh founded Azaya Therapeutics Inc. in 2002 and is the largest share holder of the company. Prior to that, Dr. Singh co-founded BioNumerik Pharmaceuticals in 1992, serving on the Board of Directors and as Vice President of Research and Development.
Dr. D. Balasubramaniam
Work in the area of Public Understanding of Science, through popular science newspaper columns, radio and TV programs; published over 300 popular articles and 6 books.
Dr. Alka Sharma
Generated and implemented clinical and basic research programmes on various aspects of stem cells. Initiated and implemented programmes in the area of Bioengineering, Genomics, clinical proteomics and RNAi.
Dr. Geeta K Vemuganti
Established and popularized Ocular Pathology, Initiated the first translational Stem Cell Therapy in India and the largest series in the world – facilitated ocular cell therapy for more than 530 cases.
Dr. Sujata Mohanty
Joined AIIMS in 1989 and progressed to the post of scientist in 1990. In 2005 she moved to the present position of Assistant professor in the Stem Cell Facility.
Dr. Deepa Bhartiya
Derivation of ES cell lines from spare embryos and also by SCNT and Parthenogenesis and Differentiation of ES cells.
Prof. V. S. Rao
An alumnus of BITS-Pilani, Prof. V S Rao is currently the Director of BITS-Pilani, Hyderabad Campus. He graduated from studentship in BITS to the present position and has been with the Institute for the last 32 years.
Dr. Arjula R. Reddy
His laboratory, has been active in sequencing a huge number of rice genes and making them available in public domain.
Mr. Suresh Narayanan
Narayanan Suresh is the Group Editor( Senior VP) of BioSpectrum. Published by CyberMedia since March 2003, BioSpectrum is India's first and only Biotechnology business magazine. Suresh is also the editor of the Asia edition of BioSpectrum, published from Singapore for a global audience.
Dr. Shrikumar Suryanarayanan
Many processes for industrial enzyme production, the design and construction of a novel bioreactor for Solid State Fermentation, pharmaceutical small molecules by fermentation and synthetic chemistry
Mr Ravi C Dasgupta
Ravi C Dasgupta is the Head - Group HR at Biocon Limited, Bangalore, one of India's leading bio-pharmaceuticals companies with a therapeutic focus in the areas of diabetes, oncology and cardiovascular disease.
Dr. S P Vasireddi
Dr. Vasireddi founded Vimtas Labs Limited in 1984 with a long-term objective of providing Contract Research and Testing services to national and international markets.
Prof. VL Chopra
Prof. Virendra Lal Chopra obtained his Associateship of Indian Agricultural Research Institute (IARI) in 1957 and Ph.D. from the University of Edinburgh in 1987. Prof. Chopra has been a researcher, administrator and a teacher.
Prof. Marc Van Montagu
He is professor emeritus, director of the Institute Plant Biotechnology for Developing Countries, Ghent University, and adviser to the Flanders Inter University Institute of Biotechnology.
Prof. Heinz Saedler
Transposable elements in plants, flower development and evolution, mechanisms of evolution of plants.
Dr. Roberto Tuberosa
Roberto Tuberosa earned a Ph.D. in Plant Breeding at the University of Minnesota, USA.
Dr. B. Sesikeran
Dr. B. Sesikeran have been working in NIN in various capacities since 1977.
Dr. G. Sarwar Gilani
Dr. Gilani, after working as a Post-Doctorate Fellow at the University of Alberta and as a Research Adviser for the Rapeseed Association of Canada, joined the scientific staff of the Bureau of Nutritional Sciences of Health Canada, Government of Canada in 1977.
Erick Boy-Gallego
A medical doctor, with a strong background in epidemiology. For the last 15 years, has been involved in international programs at INCAP/PAHO, the Micronutrient Initiative, and IFPRI and collaborating with WHO, UNICEF, PAHO, international NGOs, and local development partners, especially in Latin American region.
Dr. P. Vidyasagar
Mr. Vidyasagar Parchuri, Chairman and Managing Director of the Vibha seed Group, is an ICRISAT researcher turned entrepreneur, who established Vibha seed Group in 1995 with a vision of empowering Indian farmers to provide superior quality seeds of agri-horticultural crops.
Dr. G.B.K. Rao
A Technocrat and Industrialist, highly regarded Trust Specialist with 28 years of experience in financial management. In 1996, conceptualized and created M/s Pragati Green Meadows and Resorts a 1100 acre natural wonder.
Dr. J. L. N. Sastry
Involved in teaching and has held various administrative positions in government institutions. He was also associated with Dabur India Ltd as Medical Advisor and as Head, Clinical Research for & Dabur Research Foundation respectively. Has been pursuing private practice since July 2007.
Prof. Yamini Bhusan Tripathi
3 polyherbals patnted for various metabolic disorders namely, atherosclerosis, diabetic nephropathy, radiation protection. Now developing new formulations as PKC inhibitor, iNOS inhibitor, COX-2 inhibitor.
Dr. Taher Abbasi
Dr. Taher Abbasi has over 17 years of technology and management experience in the semiconductor engineering/chip business; automation and life sciences enabling technology industry.
Dr. Pogaku Ravindra
Dr.Pogaku Ravindra is a distinguished Professor of Bioprocess Engineering, in the Chemical Engineering Program and Postgraduate coordinator at University Malaysia Sabah (UMS), Kota kinabalu, Sabah, Malaysia.
Mr. S. Sriram
Mr. Sriram completed his MBA in Finance in 1990. He has a total of 18 years of experience mainly in Corporate Finance specializing in Mergers & Acquisitions.
Lalji Singh
Has proposed and established a new centre, the Centre for DNA Fingerprinting and Diagnostics (CDFD) at Hyderabad under the Department of Biotechnology (DBT), as an Officer on Special Duty (OSD), CDFD.
Dr. Satish Kumar
Dr. Satish Kumar is a faculty at the Centre for Cellular and Molecular Biology, Hyderabad (India) heading the 'National Facility for Transgenic and Gene Knockout Mice.
Prof. Rakesh Bhatnagar
Has nearly 35 years of research experience and close to 22 years of teaching experience.
Dr. G.S.Reddy
Dr.G.S.Reddy obtained basic degree in Veterinary medicine in 1981 from Andhra Pradesh Agricultural University, Hyderabad.
Dr. Hongxuan He
Was awarded 9 S&T awards including the second prize of Science and Technology, Trade Ministry of State of P.R. China; and the second prize of of Science and Technology, Henan Province, China.
Mr. Vivek Singhal
Was awarded 9 S&T awards including the second prize of Science and Technology, Trade Ministry of State of P.R. China; and the second prize of of Science and Technology, Henan Province, China.
Dr. Peter Langridge
Member of the Advisory Boards of the European Union BioExploit and the TriticeaeGenome Programs, the Australian Research Council Centre for Integrative Legume Research and the National Science Foundation Wheat Genomics Programs in the USA and the Institute for Biological, Environmental and Rangeland Sciences, UK.
Dr. S. R. Rao
He served in various positions in Department of Biotechnology, Ministry of Science and Technology, Government of India since 1989 and was actively involved in establishment of oil palm cultivation in India.
Dr. Kiran K. Sharma
He served in various positions in Department of Biotechnology, Ministry of Science and Technology, Government of India since 1989 and was actively involved in establishment of oil palm cultivation in India.
